Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance

Andrew M King1, Sarah A Reid-Yu2, Wenliang Wang3

  • 11] M.G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario L8S 4K1, Canada [2] Department of Chemistry and Chemical Biology, McMaster University, Hamilton, Ontario L8S 4K1, Canada.

Nature
|June 27, 2014
PubMed

Insights

A new fungal compound, aspergillomarasmine A (AMA), effectively inhibits metallo-β-lactamases (MBLs). AMA restores carbapenem antibiotic effectiveness against resistant Gram-negative pathogens, offering a potential new treatment.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Drug Discovery

Background:

  • Carbapenem-resistant Gram-negative pathogens pose a significant global health threat.
  • Metallo-β-lactamases (MBLs), like NDM-1, are key enzymes conferring resistance to critical antibiotics.
  • Existing treatments are limited due to widespread resistance.

Purpose of the Study:

  • To identify novel inhibitors of MBL enzymes.
  • To evaluate the potential of these inhibitors to restore antibiotic activity against resistant bacteria.
  • To assess therapeutic efficacy in a preclinical model.

Main Methods:

  • Screening of fungal natural products for MBL inhibitory activity.
  • Biochemical assays to determine enzyme inhibition potency.
  • In vitro testing of antibiotic re-sensitization in resistant Gram-negative bacteria.
  • In vivo efficacy studies in a mouse infection model.

Main Results:

  • Aspergillomarasmine A (AMA) was identified as a potent inhibitor of NDM-1 and VIM-2 MBLs.
  • AMA restored meropenem activity against various Gram-negative pathogens, including Enterobacteriaceae, Acinetobacter spp., and Pseudomonas spp.
  • Combination therapy with AMA and meropenem demonstrated therapeutic potential in a mouse model of Klebsiella pneumoniae infection.

Conclusions:

  • Aspergillomarasmine A is a promising MBL inhibitor with the potential to combat carbapenem resistance.
  • AMA can re-sensitize resistant Gram-negative pathogens to carbapenems.
  • Combination therapy of AMA and carbapenems offers a viable strategy to treat infections caused by MBL-producing bacteria.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
211
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
85
Antibiotic Selection00:57

Antibiotic Selection

Overview
48.8K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.3K
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
102